Wenbo Yu

1.3k total citations
31 papers, 941 citations indexed

About

Wenbo Yu is a scholar working on Immunology, Molecular Biology and Epidemiology. According to data from OpenAlex, Wenbo Yu has authored 31 papers receiving a total of 941 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 12 papers in Molecular Biology and 10 papers in Epidemiology. Recurrent topics in Wenbo Yu's work include Immunotherapy and Immune Responses (9 papers), CAR-T cell therapy research (8 papers) and Immune Cell Function and Interaction (8 papers). Wenbo Yu is often cited by papers focused on Immunotherapy and Immune Responses (9 papers), CAR-T cell therapy research (8 papers) and Immune Cell Function and Interaction (8 papers). Wenbo Yu collaborates with scholars based in Australia, China and United States. Wenbo Yu's co-authors include Tessa Gargett, Michael P. Brown, John D. Hayball, Ian D. Lewis, Susan N. Christo, Malcolm K. Brenner, Gianpietro Dotti, Eric Yvon, Zhiwei Chen and Eric J. Gowans and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Blood.

In The Last Decade

Wenbo Yu

31 papers receiving 930 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenbo Yu Australia 17 507 340 293 198 190 31 941
Douglas V. Dolfi United States 12 768 1.5× 1.2k 3.5× 219 0.7× 281 1.4× 159 0.8× 14 1.6k
Bingfeng Liu China 16 314 0.6× 318 0.9× 580 2.0× 119 0.6× 99 0.5× 38 1.1k
Angel Varela‐Rohena United States 9 1.1k 2.2× 835 2.5× 381 1.3× 114 0.6× 395 2.1× 12 1.6k
Gwendolyn Binder-Scholl United States 7 761 1.5× 340 1.0× 1.1k 3.6× 115 0.6× 658 3.5× 11 1.7k
Román Galetto United States 19 663 1.3× 210 0.6× 971 3.3× 192 1.0× 478 2.5× 51 1.6k
Martin Andreánsky United States 11 654 1.3× 287 0.8× 265 0.9× 46 0.2× 239 1.3× 21 1.0k
Damien C. Tully United States 17 471 0.9× 652 1.9× 256 0.9× 213 1.1× 60 0.3× 40 1.3k
Roberto De Pascalis United States 18 445 0.9× 721 2.1× 531 1.8× 108 0.5× 149 0.8× 32 1.4k
Andreas Bakker United States 7 398 0.8× 281 0.8× 307 1.0× 106 0.5× 289 1.5× 9 742
Murillo Silva United States 10 341 0.7× 599 1.8× 389 1.3× 79 0.4× 100 0.5× 14 1.0k

Countries citing papers authored by Wenbo Yu

Since Specialization
Citations

This map shows the geographic impact of Wenbo Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenbo Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenbo Yu more than expected).

Fields of papers citing papers by Wenbo Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenbo Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenbo Yu. The network helps show where Wenbo Yu may publish in the future.

Co-authorship network of co-authors of Wenbo Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Wenbo Yu. A scholar is included among the top collaborators of Wenbo Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenbo Yu. Wenbo Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yu, Wenbo, et al.. (2023). A Poisson distribution-based general model of cancer rates and a cancer risk-dependent theory of aging. Aging. 15(17). 8537–8551. 1 indexed citations
2.
Gargett, Tessa, Lisa M. Ebert, Nga Truong, et al.. (2022). GD2-targeting CAR-T cells enhanced by transgenic IL-15 expression are an effective and clinically feasible therapy for glioblastoma. Journal for ImmunoTherapy of Cancer. 10(9). e005187–e005187. 72 indexed citations
3.
Hughes, Amy, Wenbo Yu, Renier Myburgh, et al.. (2021). Demethylating therapy increases anti-CD123 CAR T cell cytotoxicity against acute myeloid leukemia. Nature Communications. 12(1). 6436–6436. 76 indexed citations
4.
Mekonnen, Zelalem A., Makutiro G. Masavuli, Wenbo Yu, et al.. (2020). Enhanced T Cell Responses Induced by a Necrotic Dendritic Cell Vaccine, Expressing HCV NS3. Frontiers in Microbiology. 11. 559105–559105. 4 indexed citations
5.
Gargett, Tessa, Nga Truong, Lisa M. Ebert, Wenbo Yu, & Michael P. Brown. (2019). Optimization of manufacturing conditions for chimeric antigen receptor T cells to favor cells with a central memory phenotype. Cytotherapy. 21(6). 593–602. 32 indexed citations
6.
Wijesundara, Danushka K., Wenbo Yu, Ben Quah, et al.. (2017). Cytolytic DNA vaccine encoding lytic perforin augments the maturation of- and antigen presentation by- dendritic cells in a time-dependent manner. Scientific Reports. 7(1). 8530–8530. 9 indexed citations
7.
Zou, H.‐Y., Wenbo Yu, Zhaozhi Wang, Jiang He, & Min Jiao. (2015). Human leukocyte antigen-B27 alleles in Xinjiang Uygur patients with ankylosing spondylitis. Genetics and Molecular Research. 14(2). 5652–5657. 7 indexed citations
8.
Yu, Wenbo, et al.. (2015). Engineering human rhinovirus serotype-A1 as a vaccine vector. Virus Research. 203. 72–76. 5 indexed citations
9.
Yu, Wenbo, Branka Grubor‐Bauk, Tessa Gargett, Tamsin Garrod, & Eric J. Gowans. (2014). A novel challenge model to evaluate the efficacy of hepatitis C virus vaccines in mice. Vaccine. 32(27). 3409–3416. 12 indexed citations
10.
Gargett, Tessa, Branka Grubor‐Bauk, Darren S. Miller, et al.. (2014). Increase in DNA vaccine efficacy by virosome delivery and co‐expression of a cytolytic protein. Clinical & Translational Immunology. 3(6). e18–e18. 20 indexed citations
11.
Garrod, Tamsin, Tessa Gargett, Wenbo Yu, et al.. (2014). Loss of long term protection with the inclusion of HIV pol to a DNA vaccine encoding gag. Virus Research. 192. 25–33. 6 indexed citations
12.
Yu, Wenbo, et al.. (2014). Preliminary study of the clonal characteristics of the TCR BV subfamilies in T cells in the peripheral blood from patients with uveitis. Genetics and Molecular Research. 13(1). 1296–1303. 2 indexed citations
13.
Garrod, Tamsin, Branka Grubor‐Bauk, Tessa Gargett, et al.. (2014). DNA vaccines encoding membrane‐bound or secreted forms of heat shock protein 70 exhibit improved potency. European Journal of Immunology. 44(7). 1992–2002. 23 indexed citations
14.
Zhou, Jingying, Allen Ka Loon Cheung, Zhiwu Tan, et al.. (2013). PD1-based DNA vaccine amplifies HIV-1 GAG-specific CD8+ T cells in mice. Journal of Clinical Investigation. 123(6). 2629–2642. 53 indexed citations
15.
16.
Lü, Bin, Wenbo Yu, Xiaoxing Huang, et al.. (2011). Mucosal Immunization Induces a Higher Level of Lasting Neutralizing Antibody Response in Mice by a Replication‐Competent Smallpox Vaccine: Vaccinia Tiantan Strain. BioMed Research International. 2011(1). 970424–970424. 9 indexed citations
17.
Liu, Huan, Wenbo Yu, Xian Tang, et al.. (2010). The route of inoculation determines the tissue tropism of modified vaccinia tiantan expressing the spike glycoprotein of SARS‐CoV in mice. Journal of Medical Virology. 82(5). 727–734. 11 indexed citations
18.
Yu, Wenbo, Qing Fang, Weijun Zhu, et al.. (2009). One time intranasal vaccination with a modified vaccinia Tiantan strain MVTTZCI protects animals against pathogenic viral challenge. Vaccine. 28(9). 2088–2096. 22 indexed citations
19.
Huang, Xiaoxing, Bin Lü, Wenbo Yu, et al.. (2009). A Novel Replication-Competent Vaccinia Vector MVTT Is Superior to MVA for Inducing High Levels of Neutralizing Antibody via Mucosal Vaccination. PLoS ONE. 4(1). e4180–e4180. 38 indexed citations
20.
Fang, Qing, Lin Yang, Weijun Zhu, et al.. (2005). Host range, growth property, and virulence of the smallpox vaccine: Vaccinia virus Tian Tan strain. Virology. 335(2). 242–251. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Douglas V. Dolfi Breakdown of academic impact, for papers by Bingfeng Liu Breakdown of academic impact, for papers by Angel Varela‐Rohena Breakdown of academic impact, for papers by Gwendolyn Binder-Scholl Breakdown of academic impact, for papers by Román Galetto Breakdown of academic impact, for papers by Martin Andreánsky Breakdown of academic impact, for papers by Damien C. Tully Breakdown of academic impact, for papers by Roberto De Pascalis Breakdown of academic impact, for papers by Andreas Bakker Breakdown of academic impact, for papers by Murillo Silva
Rankless by CCL
2026